A high-throughput drug screen has identified a chemical compound that reduces signs of Parkinson's disease. (IMAGE)
Caption
Stefan Pulst, MD, Dr Med, and Daniel Scoles, PhD, University of Utah Health
Credit
Charlie Ehlert
Usage Restrictions
Use with credit
License
Original content